Transcranial brain sonography findings predict disease progression in multiple sclerosis

  title={Transcranial brain sonography findings predict disease progression in multiple sclerosis},
  author={Uwe Walter and Sabine Wagner and Sebastian Horowski and Reiner Benecke and Uwe Klaus Zettl},
  pages={1010 - 1017}
Objective: In multiple sclerosis (MS), an early neurodegenerative affection of subcortical gray matter has been suggested. Transcranial sonography (TCS) shows hyperechogenic lesions of substantia nigra (SN) and basal ganglia, thought to reflect iron accumulation, in a number of primary neurodegenerative diseases. The present study deals with the question of whether TCS can also display deep gray matter lesions in patients with MS and whether sonographic findings relate to severity and… 

Figures from this paper

Width of The Third Ventricle as Assessed by Transcranial Sonography is Associated with Future Relapses in Mild Multiple Sclerosis

In this cohort of mildly diseased MS patients, 3rd ventricular enlargement assessed by TCS was associated with relapse occurrence within 3 years.

Sonographic basal ganglia alterations are related to non-motor symptoms in multiple sclerosis

The findings suggest that neurodegenerative processes affecting deep brain structures contribute to cognitive and autonomic dysfunction in MS.

Transcranial Sonography in Mitochondrial Membrane Protein-Associated Neurodegeneration

Investigations with TCS revealed a distinctive hyperechogenicity pattern of the basal ganglia in MPAN patients, which might be useful for differential diagnostics.

Transcranial sonography of deep gray nuclei

The use of TCS to assess progression in multiple sclerosis (MS) is clearly a novel idea, although similar findings have already been demonstrated in a variety of neurodegenerative diseases, including Parkinson disease, Wilson disease, and others.

Basal ganglia hyperechogenicity does not distinguish between patients with primary dystonia and healthy individuals

The basal ganglia including the substantia nigra, SN, and the ventricular system were investigated by TCS in 84 primary dystonia patients and 43 neurologically healthy controls and no characteristic abnormalities were found.

Dentate-nucleus gadolinium deposition on magnetic resonance imaging: ultrasonographic and clinical correlates in multiple sclerosis patients

DN gadolinium accumulation is not associated with trace metal accumulation, calcification, or other tissue alteration detectable on ultrasound, and neither DPSIR nor globus pallidus internus-to-thalamus T1-signal intensity-ratios were related to echo-intensity of corresponding ROI’s.

Third ventricular enlargement in early stages of multiple sclerosis is a predictor of motor and neuropsychological deficits: a cross-sectional study

Third ventricular enlargement by means of TCS seems to be a useful, clinically meaningful parameter to stage patients’ disease severity, even after considering fatigue as a relevant comorbidity.

Substantia nigra hyperechogenicity is a risk marker of Parkinson’s disease: no

  • U. Walter
  • Biology
    Journal of Neural Transmission
  • 2010
The present view summarizes current scientific evidence favouring the idea that the TCS finding of SN hyperechogenicity alone may not be a (strong) risk marker of PD.

Signs of neuroinflammation outweigh neurodegeneration as predictors for early conversion to MS

Early conversion to multiple sclerosis after first attack of demyelination is related to detection of signs of neuroinflammation rather than neurodegeneration, and Logistic regression analysis showed that heavy T2 lesion load served as the only predictor of conversion to MS.



Transcranial brain sonography findings related to neuropsychological impairment in multiple sclerosis

Application of transcranial brain sonography in MS patients and TCS findings related to neuropsychological dysfunction are reviewed, suggesting a good correlation of cognitive dysfunction and width of third ventricle which can be measured reliably with TCS.

Determination of ventricular diameters in multiple sclerosis patients with transcranial sonography (TCS)

Assessment of ventricular diameters by TCS is a reliable tool with which to monitor brain atrophy in the longitudinal follow-up of MS patients and may be used in clinical practice as well as in therapeutic trials to assess head atrophy.

Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson disease

Transcranial brain parenchyma sonography (TCS) detects lenticular nucleus hyperechogenicity, likely to be caused by copper accumulation, in neurologically symptomatic and asymptomatic patients with Wilson disease (WD).

Transcranial brain parenchyma sonography in movement disorders: state of the art.

Transcranial sonography in movement disorders.

TCS is a quick, safe and non-invasive method that could be helpful in differentiation between several movement disorders together with clinical examination and other neuroimaging methods.

T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study.

Gray matter T2 hypointensity in MS is associated with brain atrophy and is a stronger predictor of disability and clinical course than are conventional MRI findings, and results suggest that pathologic iron deposition is a surrogate marker of the destructive disease process.

Quantitative Assessment of Iron Accumulation in the Deep Gray Matter of Multiple Sclerosis by Magnetic Field Correlation Imaging

Quantitative measurements of iron content with MFC demonstrate increased accumulation of iron in the deep gray matter in patients with MS, which may be associated with the disrupted iron outflow pathway by lesions.

Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury.

It is hypothesized that transcranial sonography may identify a susceptibility marker for the development of nigral injury that can be detected early in life, prior to the onset of Parkinson disease.

Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis

Subcortical grey matter T2 hypointensity is related to cognitive impairment in MS, supporting the clinical relevance of T1-hypointensity as a biological marker of MS tissue damage and implicate a role for basal ganglia iron deposition in neuropsychological dysfunction.

Lesion pattern in patients with multiple sclerosis and depression

It is concluded that depression in MS patients is not associated with an alteration of the basal limbic system at the brainstem as seen in Parkinson's disease or unipolar depression but with an increased lesion load of the projection areas of theBasal limbic System.